Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Plateau Pearl Pharmaceutical is a specialized pharmaceutical company headquartered in Maerkang, Sichuan, China, focusing on the modernization and production of Traditional Chinese Medicine (TCM) and Tibetan medicine. The company utilizes the unique medicinal flora of the Qinghai-Tibet Plateau to develop treatments for chronic and complex diseases, particularly in the fields of rheumatology and cardiovascular health. Its flagship product, Pearl Gout Granules, is a recognized treatment for hyperuricemia and gout in the Chinese market. Sichuan Plateau Pearl Pharmaceutical operates GMP-certified production lines for various dosage forms, including granules, tablets, and capsules, and plays a significant role in the modernization of ethnic medicine. The company integrates traditional ethnic medical knowledge with modern manufacturing standards to serve patients across China. It is recognized as a key industrial enterprise in the Sichuan region, contributing to the economic development of ethnic minority areas through the pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Plateau Pearl Pharmaceutical.